Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01499121
Title Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sunnybrook Health Sciences Centre
Indications
Therapies
Age Groups: adult
Covered Countries CAN

Facility Status City State Zip Country Details
Tom Baker Cancer Centre Calgary Alberta T2N 4N2 Canada Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
BC Cancer Agency - Vancouver Vancouver British Columbia V5Z 4E6 Canada Details
CancerCare Manitoba Winnipeg Manitoba R3E 0V9 Canada Details
QEII Health Sciences Centre Halifax Nova Scotia B3H 3A7 Canada Details
Juravinski Cancer Centre Hamilton Ontario L8V 5C2 Canada Details
Kingston General Hospital Research Institute Kingston Ontario K7L 2V7 Canada Details
London Health Sciences Centre London Ontario N6A 4L6 Canada Details
Durham Regional Cancer Centre Oshawa Ontario L1G 2B9 Canada Details
Ottawa Hospital Cancer Centre Ottawa Ontario K1H 8L6 Canada Details
Sunnybrook Health Sciences Centre Toronto Ontario M4N 3M5 Canada Details
Princess Margaret Hospital Toronto Ontario M5G 2M9 Canada Details
Notre-Dame Hospital Montreal Quebec H2W 1T8 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field